1. Empagliflozin as add‐on to linagliptin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52‐week, randomized, placebo‐controlled trial. Issue 9 (1st June 2018) Authors: Kawamori, Ryuzo; Haneda, Masakazu; Suzaki, Keiko; Cheng, Gang; Shiki, Kosuke; Miyamoto, Yuki; Solimando, Fernando; Lee, Christopher; Lee, Jisoo; George, Jyothis Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 9(2018) Page Start: 2200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial. Issue 1 (6th September 2018) Authors: Kaku, Kohei; Haneda, Masakazu; Tanaka, Yuko; Lee, Ganghyuck; Shiki, Kosuke; Miyamoto, Yuki; Solimando, Fernando; Lee, Jisoo; Lee, Christopher; George, Jyothis Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 1(2019) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗